PrEP
Gemma Crawley made this Official Information request to Pharmaceutical Management Agency
The request was partially successful.
From: Gemma Crawley
Dear Pharmaceutical Management Agency,
I would like to know who requested the initial funding of PrEP.
I note that it had only been on the market for less than a year before it was funded here in New Zealand. Please can you advise the reasons behind the funding of this drug and what information you had available to the efficacy of the relatively new drug on the market.
Yours faithfully,
Gemma Crawley
From: Web Enquiry
Pharmaceutical Management Agency
Thank you for your email. We are looking into your query and will get back
to you as quickly as possible. Please note, our response time may vary
depending on the nature of your request.
[1]Keep antibiotics working
[2]https://www.pharmac.govt.nz/keepantibiot...
**********************************************************************
This email and any files transmitted with it are confidential and
intended solely for the use of the individual or entity to whom they
are addressed. If you have received this email in error please notify
the system manager.
This footnote also confirms that this email message has been swept by
MIMEsweeper for the presence of computer viruses.
www.clearswift.com
**********************************************************************
References
Visible links
2. https://www.pharmac.govt.nz/keepantibiot...
hide quoted sections
From: Web Enquiry
Pharmaceutical Management Agency
Hi Gemma thank you for your request, this information is freely available on the PHARMAC website.
You can find it here, https://www.pharmac.govt.nz/wwwtrs/Appli...
Thank you Vikki
-----Original Message-----
From: Gemma Crawley <[FYI request #10451 email]>
Sent: Tuesday, 4 June 2019 3:25 PM
To: Web Enquiry <[email address]>
Subject: Official Information request - PrEP
Dear Pharmaceutical Management Agency,
I would like to know who requested the initial funding of PrEP.
I note that it had only been on the market for less than a year before it was funded here in New Zealand. Please can you advise the reasons behind the funding of this drug and what information you had available to the efficacy of the relatively new drug on the market.
Yours faithfully,
Gemma Crawley
-------------------------------------------------------------------
This is an Official Information request made via the FYI website.
Please use this email address for all replies to this request:
[FYI request #10451 email]
Is [PHARMAC request email] the wrong address for Official Information requests to Pharmaceutical Management Agency? If so, please contact us using this form:
https://fyi.org.nz/change_request/new?bo...
Disclaimer: This message and any reply that you make will be published on the internet. Our privacy and copyright policies:
https://fyi.org.nz/help/officers
If you find this service useful as an Official Information officer, please ask your web manager to link to us from your organisation's OIA or LGOIMA page.
-------------------------------------------------------------------
**********************************************************************
This email and any files transmitted with it are confidential and
intended solely for the use of the individual or entity to whom they
are addressed. If you have received this email in error please notify
the system manager.
This footnote also confirms that this email message has been swept by
MIMEsweeper for the presence of computer viruses.
www.clearswift.com
**********************************************************************
hide quoted sections
From: Web Enquiry
Pharmaceutical Management Agency
Hi Gemma apologies the wrong link, Vikki
https://www.pharmac.govt.nz/news/notific...
-----Original Message-----
From: Gemma Crawley <[FYI request #10451 email]>
Sent: Tuesday, 4 June 2019 3:25 PM
To: Web Enquiry <[email address]>
Subject: Official Information request - PrEP
Dear Pharmaceutical Management Agency,
I would like to know who requested the initial funding of PrEP.
I note that it had only been on the market for less than a year before it was funded here in New Zealand. Please can you advise the reasons behind the funding of this drug and what information you had available to the efficacy of the relatively new drug on the market.
Yours faithfully,
Gemma Crawley
-------------------------------------------------------------------
This is an Official Information request made via the FYI website.
Please use this email address for all replies to this request:
[FYI request #10451 email]
Is [PHARMAC request email] the wrong address for Official Information requests to Pharmaceutical Management Agency? If so, please contact us using this form:
https://fyi.org.nz/change_request/new?bo...
Disclaimer: This message and any reply that you make will be published on the internet. Our privacy and copyright policies:
https://fyi.org.nz/help/officers
If you find this service useful as an Official Information officer, please ask your web manager to link to us from your organisation's OIA or LGOIMA page.
-------------------------------------------------------------------
**********************************************************************
This email and any files transmitted with it are confidential and
intended solely for the use of the individual or entity to whom they
are addressed. If you have received this email in error please notify
the system manager.
This footnote also confirms that this email message has been swept by
MIMEsweeper for the presence of computer viruses.
www.clearswift.com
**********************************************************************
hide quoted sections
Things to do with this request
- Add an annotation (to help the requester or others)
- Download a zip file of all correspondence